Food polyphenols fail to cause a biologically relevant reduction of COX-2 activity

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Willenberg, Ina ^a   Meschede, Anna K ^a   Gueler, Faikah ^b   Jang, Mi Sun ^b   Shushakova, Nelli ^b,c   Schebb, Nils Helge ^a,d  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Phenos GmbH   (Germany)

^d UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CELECOXIB; CYCLOOXYGENASE 2; EPIGALLOCATECHIN GALLATE; EPSILON VINIFERIN; GENISTEIN; HOPEAPHENOL; LIPOPOLYSACCHARIDE; NARINGENIN; NOBILETIN; POLYPHENOL; RESVERATROL; UNCLASSIFIED DRUG; WOGONIN; ANTIINFLAMMATORY AGENT; INDOMETACIN; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LIPOPOLYSACCHARIDE-INDUCED SEPSIS; MALE; MONOCYTE; MOUSE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS INHIBITION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APIGENIN; CELECOXIB; CELL LINE, TUMOR; CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME ACTIVATION; GENISTEIN; HUMANS; INDOMETHACIN; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; MONOCYTES; POLYPHENOLS; REAL-TIME POLYMERASE CHAIN REACTION; STILBENES;

EID: 84947998972     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139147     Document Type: Article

References (46)

1. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005; 81(1):317S-25S. PMID: 15640497
2. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr. 2003; 78(3):559S-69S. PMID: 12936950
3. Garcia-Lafuente A, Guillamon E, Villares A, Rostagno MA, Martinez JA. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009; 58(9):537-52. doi: 10.1007/s00011-009-0037-3 PMID: 19381780
4. Murakami A, Ohigashi H. Targeting NOX, INOS and COX-2 in inflammatory cells: Chemoprevention using food phytochemicals. Int J Cancer. 2007; 121(11):2357-63. PMID: 17893865
5. Buczynski MW, Dumlao DS, Dennis EA. Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res. 2009; 50(6):1015-38. doi: 10.1194/jlr.R900004-JLR200 PMID: 19244215
6. Al-Fayez M, Cai H, Tunstall R, Steward W, Gescher A. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemoth Pharm. 2006; 58(6):816-25.
7. Chao C-L, Weng C-S, Chang N-C, Lin J-S, Kao S-T, Ho F-M. Naringenin more effectively inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in macrophages than in microglia. Nutr Res. 2010; 30(12):858-64. doi: 10.1016/j.nutres.2010.10.011 PMID: 21147369
8. Chi YS, Jong HG, Son KH, Chang HW, Kang SS, Kim HP. Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: Cyclooxygenases and lipoxygenases. Biochem Pharmacol. 2001; 62(9):1185-91. PMID: 11705451
9. Choi S-Y, Hwang J-H, Ko H-C, Park J-G, Kim S-J. Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-kB and ROS production in LPS-activated RAW 264.7 cells. J Ethnopharmacol. 2007; 113(1):149-55. PMID: 17611060
10. Liang Y-C, Huang Y-T, Tsai S-H, Lin-Shiau S-Y, Chen C-F, Lin J-K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 1999; 20(10):1945-52. doi: 10.1093/carcin/20.10.1945 PMID: 10506109
11. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, et al. Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells. J Biol Chem. 1998; 273(34):21875-82. doi: 10.1074/jbc.273.34.21875 PMID: 9705326
12. Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, Koshimizu K, et al. Inhibitory Effect of Citrus Nobiletin on Phorbol Ester-induced Skin Inflammation, Oxidative Stress, and Tumor Promotion in Mice. Cancer Res. 2000; 60(18):5059-66. PMID: 11016629
13. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci. 2001; 68(8):921-31. PMID: 11213362
14. Wakabayashi I, Yasui K. Wogonin inhibits inducible prostaglandin E2 production in macrophages. Eur J Pharmacol. 2000; 406(3):477-81. PMID: 11040356
15. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ. Green tea polyphenol (-)-epigallocatechin-3- gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog. 2006; 45(5):309-19. PMID: 16508969
16. Cao H, Yu R, Tao Y, Nikolic D, van Breemen RB. Measurement of cyclooxygenase inhibition using liquid chromatography tandem mass spectrometry. J Pharmaceut Biomed. 2011; 54(1):230-5.
17. Sale S, Tunstall RG, Ruparelia KC, Potter GA, Steward WP, Gescher AJ. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the ApcMin+ mouse and cyclooxygenase-2 in humanderived colon cancer cells. Int J Cancer. 2005; 115(2):194-201. PMID: 15688382
18. Willenberg I, Meschede AK, Schebb NH. Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E2, D2 and thromboxane B2. J Chromatogr A. 2015; 1391:40-8. doi: 10.1016/j.chroma.2015.02.059 PMID: 25777050
19. Ostermann AI, Willenberg I, Schebb NH. Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS. Analytical and bioanalytical chemistry. 2015; 407(5):1403-14. doi: 10.1007/s00216-014-8377-4 PMID: 25542569
20. Schmelzer KR, Inceoglu B, Kubala L, Kim I-H, Jinks SL, Eiserich JP, et al. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci. 2006; 103(37):13646-51. doi: 10.1073/pnas.0605908103 PMID: 16950874
21. Mitjavila MT, Moreno JJ. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem Pharmacol. 2012; 84(9):1113-22. doi: 10.1016/j.bcp.2012.07.017 PMID: 22858365
22. Kang SS, Cuendet M, Endringer DC, Croy VL, Pezzuto JM, Lipton MA. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-ΰB. Bioorg Med Chem. 2009; 17(3):1044-54. doi: 10.1016/j.bmc.2008.04.031 PMID: 18487053
23. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure activity relationship. Bioorg Med Chem. 2004; 12 (21):5571-8. PMID: 15465334
24. Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015.
25. Simmons DL, Botting RM, Hla T. Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition. Pharmacol Rev. 2004; 56(3):387-437. doi: 10.1124/pr.56.3.3 PMID: 15317910
26. Gryglewski RJ, Krobut R, Robak J, Swies J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol. 1987; 36(3):317-22. PMID: 3101704
27. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB. The Relative Antioxidant Activities of Plant-Derived Polyphenolic Flavonoids. Free Rad Res. 1995; 22(4):375-83. doi: 10.3109/10715769509145649 PMID: 7633567.
28. Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: Mechanism and actions. Mut Res. 2005; 579(1-2):200-13.
29. Sharma RA, Gescher A, Plastaras JP, Leuratti C, Singh R, Gallacher-Horley B, et al. Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis. 2001; 22(9):1557-60. doi: 10.1093/carcin/22.9.1557 PMID: 11532880
30. Willenberg I, Brauer W, Empl MT, Schebb NH. Development of a Rapid LC-UV Method for the Investigation of Chemical and Metabolic Stability of Resveratrol Oligomers. J Agr Food Chem. 2012; 60(32):7844-50. doi: 10.1021/jf302136t
31. Ricciotti E, Fitzgerald GA. Prostaglandins and Inflammation. Arterioscler Thromb Casc Biol. 2011; 31(5):986-1000. doi: 10.1161/atvbaha.110.207449
32. Romier B, Van De Walle J, During A, Larondelle Y, Schneider YJ. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr. 2008; 100(3):542-51. doi: 10.1017/S0007114508966666 PMID: 18377686.
33. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, et al. Apigenin Blocks Lipopolysaccharide-Induced Lethality In Vivo and Proinflammatory Cytokines Expression by Inactivating NF-ΰB through the Suppression of p65 Phosphorylation. J Immunol. 2007; 179(10):7121-7. doi: 10.4049/jimmunol.179.10.7121 PMID: 17982104
34. Tam AB, Mercado EL, Hoffmann A, Niwa M. ER stress activates NF-kappaB by integrating functions of basal IKK activity, IRE1 and PERK. PloS one. 2012; 7(10):e45078. doi: 10.1371/journal.pone.0045078 PMID: 23110043; PubMed Central PMCID: PMC3482226.
35. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. The international journal of biochemistry & cell biology. 2006; 38(10):1654-61. doi: 10.1016/j.biocel.2006.03.021 PMID: 16713323.
36. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004; 79(5):727-47. PMID: 15113710
37. Scalbert A, Williamson G. Dietary Intake and Bioavailability of Polyphenols. Am J Clin Nutr. 2000; 130(8):2073S-85S.
38. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma Kinetics and Urinary Excretion of the Flavanones Naringenin and Hesperetin in Humans after Ingestion of Orange Juice and Grapefruit Juice. J Nutr. 2001; 131(2):235-41. PMID: 11160539
39. Boocock DJ, Faust GES, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidem Biomar. 2007; 16(6):1246-52. ISI:000247163100032.
40. Reddy RC, Chen GH, Tateda K, Tsai WC, Phare SM, Mancuso P, et al. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am J Physiol Lung Cell Mol Physiol. 2001; 281(3):L537-L43. PMID: 11504678
41. Schmelzer KR, Kubala L, Newman JW, Kim I-H, Eiserich JP, Hammock BD. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci. 2005; 102(28):9772-7. doi: 10.1073/pnas.0503279102 PMID: 15994227
42. Larrosa M, Azorin-Ortuno M, Yanez-Gascon MJ, Garcia-Conesa MT, Tomas-Barberan F, Espin JC. Lack of effect of oral administration of resveratrol in LPS-induced systemic inflammation. Eur J Nutr. 2011; 50(8):673-80. doi: 10.1007/s00394-011-0178-3 PMID: 21373948
43. Detampel P, Beck M, Krähenbül S, Huwyler J. Drug interaction potential of resveratrol. Drug Metab Rev. 2012; 44(3):253-65. doi: 10.3109/03602532.2012.700715 PMID: 22788578.
44. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81(1):230S-42S. PMID: 15640486
45. Martín AR, Villegas I, Sánchez-Hidalgo M, De La Lastra CA. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol. 2006; 147(8):873-85. PMID: 16474422
46. Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, et al. Resveratrol (Trans-3,5,4'-trihydroxystilbene) Induces Silent Mating Type Information Regulation-1 and Down-Regulates Nuclear Transcription Factor-kB Activation to Abrogate Dextran Sulfate Sodium-Induced Colitis. The Journal of Pharmacology and Experimental Therapeutics. 2009; 332(3):829-39. doi: 10.1124/jpet.109.160838 PMID: 19940103